tiprankstipranks

Amneal Pharmaceuticals announces expanded coverage for Crexont

Amneal Pharmaceuticals (AMRX) announced that three large insurance coverage accounts, the Veterans Administration, UnitedHealthcare (UNH) and CVS Health (CVS), have added Crexont extended-release capsules for the treatment of Parkinson’s disease to their national prescription drug formularies. Crexont is a prescription medication for the treatment of PD approved by the FDA in August 2024. This expanded coverage increases Crexont’s total U.S. insurance coverage from about 30% of covered lives at the end of 2024 to over 50%.

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue